STAT May 22, 2024
John Wilkerson

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, FDA, Govt Agencies, Patient / Consumer, Trends
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Will Trump's healthcare appointments bring 'radical changes'?
BridgeBio poised to challenge Pfizer after Attruby approval
STAT+: Trump’s FDA director pick has a history of criticizing the agency. Here are seven examples
Trump names nominees to lead CDC, FDA, and his pick for surgeon general

Share This Article